Device maker Medtronic got some bad news recently when a study showed that its new drug-coated stent was associated with more heart attacks and blood clots than a rival stent made by Johnson & Johnson. Results from the study, which included more than 2,000 patients, showed that heart patients who received the Medtronic device, called Endeavor, had more heart attacks and blood clots and needed repeat procedures more often than those treated with the J&J stent, known as Cypher.
As you know, drug-coated stents are tiny wire mesh tubular devices that are implanted in diseased vessels to prop them open. The drug coating is designed to keep vessels from reclogging. Interestingly, this study was sponsored by J&J. It showed there was no difference in death rates. The study, called Sort Out III, was presented at the Transcatheter Cardiovascular Therapeutics meeting in Washington D.C. Medtronic says the J&J study is at odds with every other study that has been done. In any event, the release of the study wasn’t good news for Medtronic.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.